drugset / Trial / NCT06861088
The Effect of Kinisoquin™ on Thromboembolic Events in Patients With Metastatic or Locally Advanced Pancreatic Cancer
RandomizedParallel-groupQuadruple-blindPrevention
Summary
The aim of this Phase 3 study is to evaluate the efficacy of Kinisoquin™ as compared to the placebo in prevention of thromboembolic events in patients with metastatic or locally advanced pancreatic cancer.
Timeline
- Start
- 2025-12-19
- Primary completion
- 2027-10-31
- Completion
- 2029-10-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Isoquercetin | Small molecule | 1000 mg | Oral |
| Subject | Isoquercetin | Small molecule | 2000 mg | Oral |